AMANTA Share Price | Amanta Healthcare Ltd Stock Analysis & Recommendation

Q: Are Amanta Healthcare Ltd latest results good or bad?

Amanta Healthcare Ltd's latest results present a mixed picture. On one hand, the company reported a significant net profit of ₹4.63 crores for Q3 FY26, which is a remarkable 282.64% increase compared to the previous quarter. This surge in profit is primarily attributed to reduced interest costs and improved tax efficiency rather than operational performance, as the revenue growth was more modest at 9.85% year-on-year, reaching ₹74.49 crores.However, the operating margin has contracted by 159 basis points to 20.62%, indicating challenges in maintaining profitability amidst rising costs and competitive pressures. Additionally, while the nine-month net profit has shown a substantial improvement of 73.88% compared to the previous year, this growth has come against a backdrop of only 6.46% revenue expansion.Overall, while the profit growth is impressive, the underlying issues such as margin compression and capital efficiency concerns suggest that the company is facing significant operational challenges. Therefore, while there are positive aspects, the overall outlook remains cautious due to these structural weaknesses.

Q: Why is Amanta Healthcare Ltd falling/rising?

As of 05-May, Amanta Healthcare Ltd's stock price is currently falling, with a change of -2.55, representing a decline of 1.82%. This downward movement follows a trend reversal after two consecutive days of gains. The stock has also underperformed its sector by 2.69% today. Additionally, it reached an intraday low of Rs 135.35, which is a decrease of 3.53% from its previous price.Despite these short-term declines, it is noteworthy that Amanta Healthcare Ltd has shown strong performance over the past week and month, with increases of 3.92% and 26.98%, respectively. Furthermore, the stock is trading above its moving averages across various time frames, indicating a generally positive long-term trend. However, the current price drop suggests that immediate market conditions or investor sentiment may be influencing the stock negatively at this time.

Q: Should I buy, sell or hold Amanta Healthcare Ltd?

Based on the current analysis of Amanta Healthcare Ltd, it would be prudent to hold your position in the stock for now. The company has demonstrated strong recent performance, with a significant growth in profit after tax of 73.88% and record net sales of Rs 74.49 crore. Additionally, the operating profit to interest ratio is at its highest, indicating a solid ability to cover interest expenses.The attractive valuation, highlighted by a return on capital employed (ROCE) of 14 and a low enterprise value to capital employed ratio of 2.1, suggests that the stock is reasonably priced. Furthermore, the increase in institutional investor participation, which now stands at 13.72%, reflects growing confidence in the company's fundamentals.However, it's important to consider the long-term outlook. The company has faced challenges, evidenced by a negative compound annual growth rate (CAGR) of -2.00% in net sales over the past five years and a high debt to EBITDA ratio of 3.11, indicating potential difficulties in servicing its debt.In summary, while the short-term indicators are positive, the long-term fundamental weaknesses suggest that holding the stock may be the best strategy at this time.

Technical Trend Update: Amanta Healthcar witnessed a change in Technical Grade on 04 May 2026. Click here to discover latest technical change!

Mojo Score Change: Amanta Healthcar has changed its score on 05 May 2026. Click here to unlock latest mojo score!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

69.62 k (-36.21%) Volume

Shareholding (Mar 2026)

FII

0.85%

Held by 4 FIIs

DII

7.74%

Held by 7 DIIs

Promoter

63.72%

Are Amanta Healthcare Ltd latest results good or bad?

11-Feb-2026

Amanta Healthcare Ltd's latest results show a significant net profit increase of 282.64% to ₹4.63 crores, but revenue growth is modest at 9.85% and operating margins have contracted, indicating underlying operational challenges. Overall, while profit growth is strong, caution is warranted due to margin compression and capital efficiency concerns.

View full answer

Why is Amanta Healthcare Ltd falling/rising?

06-May-2026

As of 05-May, Amanta Healthcare Ltd's stock is experiencing a decline of 1.82% after two days of gains, underperforming its sector by 2.69%. Despite this short-term drop, the stock has shown strong performance over the past week and month, indicating a generally positive long-term trend.

View full answer

Which are the latest news on Amanta Healthcar?

06-May-2026

Amanta Healthcare Ltd Upgraded to Hold by MarketsMOJO Amid Technical and Financial Improvements
Amanta Healthcare Ltd Sees Technical Momentum Shift Amid Strong Price Gains

Should I buy, sell or hold Amanta Healthcare Ltd?

06-May-2026

Compare Amanta Healthcar with Similar Stocks

Kilitch Drugs CCME Global Shree Ganesh Rem

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Weak Long Term Fundamental Strength with a -2.00% CAGR growth in Net Sales over the last 5 years

Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.11 times

Positive results in Dec 25

With ROCE of 14, it has a Attractive valuation with a 2.1 Enterprise value to Capital Employed

Increasing Participation by Institutional Investors

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 533 Cr (Micro Cap)

P/E

31.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.40

Return on Equity

4.98%

Price to Book

2.53

Revenue and Profits:

Net Sales:

74 Cr

(Quarterly Results - Dec 2025)

Net Profit:

5 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

28.17%

6 Months

11.77%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Amanta Healthcar for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

Amanta Healthcare Ltd Upgraded to Hold by MarketsMOJO Amid Technical and Financial Improvements

Amanta Healthcare Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and financial performance. The upgrade, effective from 5 May 2026, is driven by a combination of enhanced technical trends, robust quarterly financial results, attractive valuation metrics, and increased institutional participation, despite some lingering concerns over long-term fundamentals and debt servicing capacity.

Read full news article

Amanta Healthcare Ltd Sees Technical Momentum Shift Amid Strong Price Gains

Amanta Healthcare Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a strong day change of 6.73% and a current price of ₹140.30, the stock’s technical indicators present a nuanced picture, with bullish signals from MACD and Bollinger Bands contrasting with bearish RSI readings. This article analyses these technical parameters in detail, placing the stock’s performance in the context of broader market trends and its sector.

Read full news article

Amanta Healthcare Ltd Technical Momentum Shifts Amid Mixed Market Signals

Amanta Healthcare Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a modest day gain of 0.44%, the stock’s recent performance and technical signals suggest a cautious outlook amid mixed momentum cues.

Read full news article

Announcements

No announcement available

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-2.00%

EBIT Growth (5y)

9.30%

EBIT to Interest (avg)

1.30

Debt to EBITDA (avg)

3.27

Net Debt to Equity (avg)

1.99

Sales to Capital Employed (avg)

0.80

Tax Ratio

28.62%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

13.72%

ROCE (avg)

13.97%

ROE (avg)

8.18%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.50

EV to EBIT

14.77

EV to EBITDA

10.21

EV to Capital Employed

2.07

EV to Sales

2.22

PEG Ratio

Dividend Yield

ROCE (Latest)

14.03%

ROE (Latest)

4.98%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

Bearish

Bollinger Bands

Bullish

KST

Dow Theory

Mildly Bullish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (5.09%)

FIIs

Held by 4 FIIs (0.85%)

Promoter with highest holding

Bhavesh Girishbhai Patel (16.25%)

Highest Public shareholder

Bandhan Small Cap Fund (5.09%)

Individual Investors Holdings

16.0%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 5.08% vs 8.54% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 282.64% vs -65.53% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "74.49",
          "val2": "70.89",
          "chgp": "5.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.36",
          "val2": "14.65",
          "chgp": "4.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.06",
          "val2": "5.15",
          "chgp": "-1.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-2.63",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.63",
          "val2": "1.21",
          "chgp": "282.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.62%",
          "val2": "20.67%",
          "chgp": "-0.05%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "136.19",
          "val2": "134.83",
          "chgp": "1.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "29.54",
          "val2": "27.28",
          "chgp": "8.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "11.44",
          "val2": "15.77",
          "chgp": "-27.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.63",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.71",
          "val2": "1.90",
          "chgp": "147.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.69%",
          "val2": "20.23%",
          "chgp": "1.46%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "210.68",
          "val2": "202.64",
          "chgp": "3.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "44.90",
          "val2": "42.34",
          "chgp": "6.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "16.50",
          "val2": "21.67",
          "chgp": "-23.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.63",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.34",
          "val2": "6.18",
          "chgp": "51.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.31%",
          "val2": "20.89%",
          "chgp": "0.42%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "274.71",
          "val2": "280.34",
          "chgp": "-2.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "59.67",
          "val2": "57.49",
          "chgp": "3.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "27.95",
          "val2": "33.64",
          "chgp": "-16.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "10.50",
          "val2": "3.63",
          "chgp": "189.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.72%",
          "val2": "20.51%",
          "chgp": "1.21%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

74.49

70.89

5.08%

Operating Profit (PBDIT) excl Other Income

15.36

14.65

4.85%

Interest

5.06

5.15

-1.75%

Exceptional Items

0.00

-2.63

100.00%

Standalone Net Profit

4.63

1.21

282.64%

Operating Profit Margin (Excl OI)

20.62%

20.67%

-0.05%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 5.08% vs 8.54% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 282.64% vs -65.53% in Sep 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

136.19

134.83

1.01%

Operating Profit (PBDIT) excl Other Income

29.54

27.28

8.28%

Interest

11.44

15.77

-27.46%

Exceptional Items

-2.63

0.00

Standalone Net Profit

4.71

1.90

147.89%

Operating Profit Margin (Excl OI)

21.69%

20.23%

1.46%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

210.68

202.64

3.97%

Operating Profit (PBDIT) excl Other Income

44.90

42.34

6.05%

Interest

16.50

21.67

-23.86%

Exceptional Items

-2.63

0.00

Standalone Net Profit

9.34

6.18

51.13%

Operating Profit Margin (Excl OI)

21.31%

20.89%

0.42%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

274.71

280.34

-2.01%

Operating Profit (PBDIT) excl Other Income

59.67

57.49

3.79%

Interest

27.95

33.64

-16.91%

Exceptional Items

0.00

Standalone Net Profit

10.50

3.63

189.26%

Operating Profit Margin (Excl OI)

21.72%

20.51%

1.21%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Amanta Healthcare Ltd

Amanta Healthcare Ltd

Micro Cap

Pharmaceuticals & Biotechnology

Amanta Healthcare Limited was originally incorporated on December 21, 1994 as Marck Parenterals (India) Limited with RoC, Gujarat, at Ahmedabad by converting the existing Partnership Firm "Marck Parenterals (India)" on January 06, 1995. The Company name was changed to "Marck Biosciences Limited" vide a fresh Certificate of Incorporation issued by the Registrar of Companies, Gujarat, at Ahmedabad, dated November 2, 2005 and was again changed to "Amanta Healthcare Limited" dated June 24, 2014.

Company Coordinates

No Company Details Available